Skip to main content
U.S. flag

An official website of the United States government

This site is currently in beta, and your feedback is helping shape its ongoing development.

Divalproex sodium

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Metadata Last Checked: February 18, 2026 | Last Modified: 2025-03-17
Divalproex Sodium is a generic prescription drug available as extended-release oral tablets in 250 mg and 500 mg strengths (equivalent to valproic acid). It acts as an anti-epileptic agent and mood stabilizer, commonly used for seizure control and bipolar disorder management. Manufactured by BluePoint Laboratories and Unichem Pharmaceuticals (USA), Inc., under FDA application ANDA214643. This information was generated using AI and is provided for informational and research purposes only.

Find Related Datasets

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov